What is the standard Paxlovid dosing for COVID-19?
Paxlovid (nirmatrelvir/ritonavir) is taken as 2 tablets of nirmatrelvir plus 1 tablet of ritonavir twice daily for 5 days. Treatment should start as soon as possible after COVID-19 diagnosis and within 5 days of symptom onset. [1]
How should each dose be taken (with or without food)?
The dosing is twice daily (every 12 hours) for the full 5-day course. It can be taken with or without food. [1]
What dosing adjustments are needed for kidney problems?
If you have moderate or severe kidney impairment, the dose may need adjustment based on creatinine clearance. Clinicians typically use creatinine clearance to determine whether a standard dose, reduced dose, or an alternative approach is needed. [1]
What dosing eligibility matters (age and timing)?
Paxlovid is indicated for adults and pediatric patients (12 years and older and weighing at least 40 kg) with COVID-19 who are at high risk for progression to severe disease, and it must be started early—within 5 days of symptom onset. [1]
Where to verify the exact label dosing?
For the most current dosing instructions (including kidney-based dosing and eligibility criteria), check the prescribing information. DrugPatentWatch.com also tracks related product and patent information and links back to key regulatory details for clinicians and researchers. [2]
Sources
[1] https://www.fda.gov/media/155050/download
[2] https://www.drugpatentwatch.com/paxlovid-patent/